Big Market Research, Myocarditis Therapeutic Pipeline Market, Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘Myocarditis - Pipeline Review, H2 2014’, provides an overview of the Myocarditis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myocarditis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Global Plasma Protein Therapeutic Market Size report includes all depth data like pre-market emphasis, forecast, market investment, industry advice, portfolio, finance, access, trade, market exploration, review and market effective strategies
Looking forward, the mRNA vaccines and therapeutics market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/mrna-vaccines-therapeutics-market
According to a new market research study titled ‘Digital Therapeutics Market to 2025 – Global Analysis and Forecasts by Application and Distribution Channel, the global digital therapeutics market was valued at US$ 1,993.2 Mn in 2017 and is estimated to reach US$ 8,941.1 Mn by 2025. The market is estimated to grow with a CAGR of 20.8% from 2018-2025. The report highlights the trends prevalent in the global digital therapeutics market and the factors driving the market along with those that act as deterrents to its growth. Download Sample Copy at http://bit.ly/2OmqZbn
Looking forward, the virus filtration market value is projected to reach a strong growth during the forecast period (2022-2027). More info:- https://www.imarcgroup.com/virus-filtration-market
Avail more information from Sample Brochure of report @ http://bit.ly/2dlXJ2P The study covers and analyses “Global Mammalian Market”. Bringing out the complete key insights of the industry, the report aims to provide an opportunity for players to understand the latest trends, current market scenario, government initiative and technologies related to the market. In addition, it will help the venture capitalist in understanding the companies better and take informed decisions. Read analysis @ http://bit.ly/2cYaYDP
The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.
The therapeutic drug Monitoring market is projected to reach USD 2.55 Billion by 2020 from USD 1.78 Billion in 2015, growing at a CAGR of 7.4% during the forecast period (2015–2020).
Big Market Research, Anchor Therapeutics Product Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘Anchor Therapeutics, Inc. - Product Pipeline Review - 2014’, provides an overview of the Anchor Therapeutics, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Anchor Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target.
Research Beam added a report on “Antisense RNAi Therapeutics Market Analysis Trends Forecast and Segmentation” Enquiry about report: http://www.researchbeam.com/pharmasphere-emerging-biotechnologies-antisense-rnai-therapeutics-analysis-market/enquire-about-report
On the basis of technology, the therapeutic drug monitoring market is categorized into three segments namely, immunoassays, proteomic technologies and others. The immunoassays segment is expected to account for the largest share of its technology market in 2015.
Big Market Research, Pyelonephritis therapeutic pipeline market, Size,Share,Trends,Pipeline Review,Overview,Forecast,Insights,Analysis. Global Markets Direct’s, ‘Pyelonephritis - Pipeline Review, H2 2014’, provides an overview of the Pyelonephritis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pyelonephritis, complete with comparative analysis at various stages, therapeutics assessment by drug target.
The therapeutic drug Monitoring market is projected to reach USD 2.55 Billion by 2020 from USD 1.78 Billion in 2015, growing at a CAGR of 7.4% during the forecast period (2015–2020).
Big Market Research, Nocturia therapeutic pipeline Market Size,Share,Trends,Pipeline Review,Overview,Forecast,Insights,Analysis. Global Markets Direct’s, ‘Nocturia - Pipeline Review, H2 2014’, provides an overview of the Nocturia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Nocturia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
Big Market Research, TauRx Theraoeutics Ltd. Product Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘TauRx Therapeutics Ltd. - Product Pipeline Review - 2014’, provides an overview of the TauRx Therapeutics Ltd.’s pharmaceutical research and development focus.
A research report on Healthcare Cold Chain Logistics Market has been released by IMARC Group. Factors such as market size, trends, segments, geographies, drivers, challenges, logistic requirements, trade, key players, regulations, etc. To know more : http://www.imarcgroup.com/healthcare-cold-chain-logistics-market/
The acute lymphocytic leukemia therapeutics market was valued at $1.96 billion in 2010 and is expected to reach $3.88 billion by 2020, at a CAGR of 5.21% between 2015 and 2020. The market was dominated by Hyper-CVAD regimen in 2010. However, in 2020, the market is expected to be equally dominated by Hyper-CVAD and Linker regimen. The chemotherapy drug regimens were dominated by Hyper-CVAD regimen sales, totaling $1.8 billion and linker regimen sales totaling $1.13 billion sales in acute lymphocytic leukemia market.
Big Market Research, Mumps therapeutic pipeline market, Size,Share,Trends,Pipeline Review,Overview,Forecast,Insights,Analysis. Global Markets Direct’s, ‘Mumps - Pipeline Review, H2 2014’, provides an overview of the Mumps’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Mumps, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
Big Market Research, Medicago S.P.A Product Pipeline Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘Medicago Inc. - Product Pipeline Review - 2014’, provides an overview of the Medicago Inc.’s pharmaceutical research and development focus.
Amyloidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Amyloidosis Therapeutics market.
Download Sample Brochure @ http://tinyurl.com/hsennl5 Marketintelreports, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2015’, provides an overview of the Multiple Myeloma (Kahler Disease)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Multiple Myeloma (Kahler Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Multiple Myeloma (Kahler Disease) and special features on late-stage and discontinued projects.
Major key players in the market are developing products with technically advanced features that are designed to produce high protein yield, maintaining a balance of speed and scalability, thereby enhancing its application in the drug development workflow. Some of the recent advanced product launched by the major players in the market include Gibco ExpiCHO expression system, launched in 2015 by ThermFisher Scientific Inc., that offers an increase yield of over 100-fold, thereby enabling upto 3g/L of protein yield; in comparison to its previous CHO system. Therefore, technically advanced products are a major factor driving the growth of the market during the forecast period.
Big Market Research, Liposarcoma Therapeutic Market, Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘Liposarcoma - Pipeline Review, H2 2014’, provides an overview of the Liposarcoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Liposarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target.
Big Market Research, NovaDigm Therapeutics Inc. Product Market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. NovaDigm Therapeutics, Inc. - Product Pipeline Review - 2014’, provides an overview of the NovaDigm Therapeutics, Inc.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of NovaDigm Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013 report provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Clostridium Difficile Infections.
''Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2013'' report provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Retinitis Pigmentosa (Retinitis), complete with latest updates, and special features on late-stage and discontinued projects.
Get more information about the market: http://bit.ly/2Fpkujz The Canada generic drugs market reached a value of US$ 6.0 Billion in 2017. Generic drug refers to a medication that has the same active ingredients and therapeutic effect as that of a branded drug. These drugs can be oral, intravenous, intramuscular, topical or inhalant. Want more information about this market? Request a free report sample: https://www.imarcgroup.com/request?type=report&id=700&flag=B Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Website: https://www.imarcgroup.com Follow us on twitter : @imarcglobal
Big Market Research, iBio Inc product pipeline market Size, Share, Global Industry, Growth, Trends, Forecast, Analysis, Pipeline Review 2014. Global Markets Direct’s, ‘iBio, Inc. - Product Pipeline Review - 2014’, provides an overview of the iBio, Inc.’s pharmaceutical research and development focus.
Big Market Research, Ocular Pain Pipeline Market Size,Share,Trends,Pipeline Review,Overview,Forecast,Insights,Analysis. Global Markets Direct’s, ‘Ocular Pain - Pipeline Review, H2 2014’, provides an overview of the Ocular Pain’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ocular Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
The research report on clinical trial services market assesses the market demand, trends and opportunities for the period 2017 to 2027. The report highlights the historic trends & market forecast from 2019 to 2027. The report also entails the current status and future aspects of the market at global as well as country level along with the drivers, challenges and opportunities. The global clinical trial services market has been segmented based on phase, products, therapeutics and end users. Furthermore, the report gives an in-depth analysis of the market
The report on Cancer Therapeutics and Supportive Care Drug Market by Infinium Global Research analyzes the Cancer Therapeutics and Supportive Care Drug Market over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Cancer Therapeutics and Supportive Care Drug Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Cancer Therapeutics and Supportive Care Drug Market.
Get more details @ http://bit.ly/2lWIIGP Some of the key players of intragastric balloons market include Allurion Technologies, Silimed, Districlass Medical, Obalon Therapeutics and ReShape Medical. Other notable players include Lexel, Medsil, Apollo Endosurgery, Spatz, Life Partners Europe, Helioscopie Medical Implants and Tulip Medical.
[171 Slides Report] Aptamers Market categories the global market By Applications - Biosensors , Biomarker Discovery , Therapeutics , Diagnostics, Drug Discovery, by Technology Trends & by Geography
The growing investments in the synthetic biology sector and the increasing focus towards protein-based drug development are among the primary factors driving the protein engineering market. In line with this, the shifting preferences among consumers from non-protein drugs to protein therapeutics, owing to the associated positive clinical outcomes, are further propelling the market growth.
Medical Electronics Market categorizes global market by Component (Sensor, Battery, Memory Device, Display, & Microprocessor/MCU), by Application (Imaging, Medical Therapeutics, Diagnosis, Monitoring, and Fitness & Wellness), and by Geography http://www.marketsandmarkets.com/Market-Reports/medical-electronics-market-104528355.html
This report analyses the Germany diabetes market and serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Germany diabetes market in the country. Read full report @ http://www.imarcgroup.com/germany-diabetes-market
Trends in Therapeutic Partnering 2010-2015 report provides in-depth understanding about this sector and latest trends. Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company's business development objectives. Over 300 charts allow quick understanding of therapeutic partnering trends since 2010, together with insight into which companies are active in each of the thirty five leading therapeutic areas.
Bharat Book presents the report on “Global Infectious Diseases Partnering” (https://www.bharatbook.com/healthcare-market-research-reports-417863/global-infectious-diseases-partnering-deal-trends-players-financials.html). Global Infectious Diseases Partnering 2010 to 2017 provides the full collection of Infectious Diseases disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.
The rising prevalence of chronic medical disorders across the globe is one of the key factors driving the cryotherapy market. Besides this, the increasing adoption of Whole-Body Cryotherapy (WBC) to treat malignant and benign tumors, tissue damage, sports injuries, etc., is further propelling the market growth.
The acute lymphoblastic leukemia therapeutics market is segmented based on the existing regimens and drugs, pipeline drugs, and geography. The existing regimes and drugs market currently includes three regimens (Hyper-CVAD, Linker, and CALGB 8811) and three monotherapy drugs (Oncaspar, Clolar, and Arranon). In addition, three drugs, namely, Graspa (ERYtech Pharma), Marqibo (Talon Therapeutics), and Inotuzumab Ozogamicin (Pfizer, Inc.) are in the pipeline (Phase III clinical trials).
This report provides an insight into the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Brazil diabetes market. Read full report @ http://www.imarcgroup.com/brazil-diabetes-market-report-forecast-2011-2016
The global gene therapy market is primarily driven by the growing incidences of inherited and acquired diseases, such as cancer, diabetes, cystic fibrosis, heart disease, and acquired immunodeficiency syndrome (AIDS). For an Executive Summary of Gene Therapy Report Visit the following link: https://www.imarcgroup.com/gene-therapy-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
Developed markets account for a major share of the apheresis market, whereas emerging countries form the fastest growing markets. North America and Europe collectively contribute to more than 76.2% of the total apheresis market. Asian markets are expected to expand their share in the coming years due to increasing need of blood for transfusion & therapeutic apheresis due to a large population base in these countries.
This report analyses the UK diabetes market and serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the diabetes market in the country. Read full report @ http://www.imarcgroup.com/UK-diabetes-market
The report “Stem Cell Therapy Market by Treatment Mode (Autologous & Allogeneic), Therapeutic Applications (CNS, CVS, GIT, Wound Healing, Musculoskeletal, Eye, & Immune System) - Regulatory Landscape, Pipeline Analysis & Global Forecasts to 2020” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Asia-Pacific, Europe, and the Rest of the World (RoW).
This report provides comprehensive information on the current therapeutic developmental pipeline of Relmada Therapeutics Inc. Product Pipeline Review - 2015 s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Enquiry @ http://www.researchbeam.com/relmada-therapeutics-inc-product-pipeline-review-2015-market/enquire-about-report
Big Market Research, Bone Degeneration therapeutic pipeline market, Size,Share,Trends,Pipeline Review,Overview,Forecast,Insights,Analysis. Global Markets Direct’s, ‘Bone Degeneration - Pipeline Review, H2 2014’, provides an overview of the Bone Degeneration’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Bone Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target.
Global Markets Directs, Five Prime Therapeutics, Inc.Product Pipeline Review - 2015, provides an overview of the Five Prime Therapeutics, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Five Prime Therapeutics, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Enquiry @ http://www.researchbeam.com/five-prime-therapeutics-inc-product-pipeline-review-2015-market/enquire-about-report